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The Keystone Symposium on Genome Instability and DNA Repair took 
place between 1 and 6 March 2009, in Taos, New Mexico, and was 
organized by M. Jasin, S.J. Elledge & M.S. Neuberger.
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Introduction
DSBs occur when both strands of a DNA double helix are damaged 
by either the normal metabolic processes of the cell, or environ-
mental factors such as ultraviolet light or radiation. Cells have 
evolved mechanisms to repair DSBs, to ensure that large pieces of the 
genome are not lost; however, the aberrant repair of DSBs can lead 
to genome rearrangements that scramble the information encoded 
in the DNA. The 2009 Keystone Symposium on Genome Instability 
and DNA Repair featured mechanistic studies of DSB repair, host 
responses to DSBs and recent phenomenology in human genomic 
disorders. This report highlights some of the key findings presented 
at the meeting. Space limitations have prevented us from discussing 
every contribution, and we apologize to those whose work is not 
highlighted in this report.
DSBs: formation, repair and signalling events
One way to understand the consequences of aberrant DSB repair is 
to identify and characterize genomic rearrangements. M. Stratton 
(Cambridge, UK) used second-generation whole-genome DNA-
sequencing technologies to characterize the most common types 
of DNA rearrangement in a range of cancer cell lines and primary 
tumours. In addition to finding a large number of point mutations in 
these samples, preliminary analyses of the data indicate that many 
rearrange ments result from intrachromosomal events, and, less fre-
quently, interchromosomal breakage and rejoining events. Importantly, 
many of these rearrangements had not been seen previously because 
they are too small to be detected by conventional karyotype analyses. 
The analysis of junction sequences by the Stratton group also revealed 
that classical repair processes such as HR and NHEJ, probably have 
a role in the formation of these rearrangements. However, he also 
observed a distinct pattern of insertion events, which involved nearby, 
unlinked or unknown segments of DNA that might result from non-
classical DSB repair events such as single-strand annealing, template 
switching or break-induced replication. Therefore, the mutations and 
DNA rearrangements that occur in tumour cells are more varied and 
complex than previously thought.
Although intriguing, Stratton’s findings are based on inference. 
Yet, understanding DSB repair necessitates learning more about 
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what happens to these lesions soon after they arise. Important contri-
butions towards this goal came from L. Symington (New York, NY, 
USA) and G. Ira (Houston, TX, USA), who presented studies on the 
MRN complex, which has a 3'–5' exonuclease/endonuclease activity 
in vitro that seems to be incompatible with the proposed 5'–3' exo-
nuclease activity that is needed to promote 3'-overhang formation 
in vivo (Mimitou & Symington, 2008; Zhu et al 2008). Symington and 
Ira demonstrated that this paradox might be resolved by the activ-
ity of the SGS1 helicase in vivo, which unwinds DNA and displaces 
single-stranded DNA in the 5'–3' direction. The single-stranded DNA 
is processed initially by the MRN complex and then by the DNA2 
exonuclease/endonuclease, which acts redundantly with ExoI to 
degrade the 5' strand (Fig 1). Their findings seem to have resolved 
a longstanding question in DSB processing and explain how 3' 
overhangs are generated for use in HR-based DNA repair.
Another clue about the role of the MRN nuclease came from 
D. Ferguson (Ann Arbor, MI, USA). Ferguson used knock-in 
techno logy to create mice containing a nuclease-deficient allele 
of Mre11 (Buis et al, 2008). Remarkably, these mice exhibited 
phenotypes that were indistinguishable from those of mice lack-
ing the Mre11 gene, including early embryonic lethality and 
genomic instability; however, in contrast to Mre11-knockout 
cells, ATM signalling is not affected in MRE11 nuclease-deficient 
cells. Therefore, unlike simple eukaryotes such as Saccharomyces 
cerevisiae, higher eukaryotes probably have a low tolerance for 
DSBs and use a range of recombination-based processes to repair 
these lesions rapidly in order to avoid cell death.
HR has been studied extensively and involves the formation 
of a Holliday junction (HJ) intermediate. The symmetrical cleavage 
of the HJ by an enzyme known as resolvase allows for the cleav-
age of the resultant duplexes (Liu & West, 2004). S. West (South 
Mimms, UK) reported the identification of the human (GEN1) and 
yeast (Yen1) HJ resolvases (Ip et al, 2008). Unlike previously iden-
tified nucleases—for example, Mus81–Mms4/EME1—GEN1 and 
Yen1 cleave model HJ substrates at symmetrical positions, yielding 
nicked duplexes that can be ligated without further processing. The 
identification of GEN1/Yen1 is a crucial breakthrough that will make 
its mark on many processes that involve HR-based repair.
Several talks also addressed how DSBs are formed during the nor-
mal cell cycle. Torsional stress can occur during DNA replication- 
fork elongation, especially when two replicons fuse together at 
termination or when the replication forks encounter transcription 
units. The topoisomerase-mediated resolution of these constraints 
then allows the completion of S phase, and subsequent chromo-
some condensation and segregation. However, interfering with this 
process can result in entangled DNA molecules and DNA breaks, 
leading to intra-S-phase DNA lesions and/or segregation abnormal-
ities. Using genomic approaches, M. Foiani (Milan, Italy) character-
ized regions where replication termination occurs in S. cerevisiae 
and identified cellular pathways that are required for the resolution 
of two converging forks. Importantly, these replication-termination 
zones might represent replication-risk elements that are prone to 
genome rearrangements, unscheduled recombination events and 
even DNA breakage.
The efficient activation of the DNA-damage response might also 
be important for inducing chromatin modifications that promote 
an effective repair of DSBs. Following a DSB, ubiquitination of the 
damaged chromatin attracts BRCA1 complexes. How BRCA1 acts 
at the sites of DNA damage remains ill defined. The Ludwig labora-
tory (New York, NY, USA) showed that the ubiquitin ligase activity 
of BRCA1 is not essential for HR or the response to DNA-damaging 
agents, and therefore seems to be dispensable for DSB repair (Reid 
et al, 2008). However, it is clear that BRCA1 forms distinct sub-
complexes. S. Elledge (Boston, MA, USA) reported the identifica-
tion of a new component of the BRCA1 A-complex, NBA1, which 
is required for the recruitment of BRCA1 to sites of DNA damage. 
NBA1 also has a crucial role in ionizing-radiation resistance and 
cell-cycle control. Intriguingly, analyses of NBA1 and the other 
components of the BRCA1 A-complex revealed marked similari-
ties to the lid complex of the 26S proteasome (Wang et al, 2009). 
Does the BRCA1 A-complex recruit the 26S proteasome to DSBs? If 
so, this groundbreaking finding is likely to shed light on the role of 
BRCA1 in DNA repair and cancer.
Chromosomal translocations are also a characteristic of many 
cancers. To identify proteins that affect translocation, M. Jasin (New 
York, NY, USA) used the rare endonuclease I-SceI to introduce 
DSBs at two different chromosomal loci in either wild-type mouse 
cells or mutants lacking proteins that are important for NHEJ—such 
as XRCC4 and Ku70 (Weinstock et al, 2007). Jasin reported a three- 
to fivefold increase in translocations in both Xrcc4-deficient and 
Glossary
A-complex protein complex containing BRCA1 and NBA1, and other  
 proteins
AID activation-induced cytidine deaminase
ATM ataxia telangiectasia mutated
BCL B-cell leukaemia lymphoma
BRCA1 breast cancer 1
c-Myc avian myelocytomatosis virus oncogene cellular homologue
CNV copy-number variant
CpG cytosine guanine
Crm-1 chromosome region-maintenance 1
CSR class-switch recombination
DNA2 DNA nuclease 2
DSB double-strand break
Dsbc1 double-strand break control 1
E2A E2A immunoglobulin enhancer-binding factors E12/E47;  
 also known as transcription factor 3 (TCF3)
EME1 essential meiotic endonuclease 1
ExoI exonuclease I
GEN1 XPG-like endonuclease 
HR homologous recombination
IgH immunoglobulin heavy-chain locus
I-Sce1 a rare cutting restriction endonuclease encoded by the 
 Saccharomyces cerevisiae mitochondrial intron, omega
Ku70 70 kDa Ku antigen
Mms4 methyl methanesulphonate sensitive 4
Mre11 meiotic recombination 11
MRN Mre11–Rad50–Nbs1 complex
Mus81 methyl methane sulphonate and ultraviolet sensitive 81
NBA1 new component of the BRCA1 A complex
NHEJ non-homologous end joining
RAG1/2 recombination-activating gene 1/2
Rcr1 recombination regulator 1
SGS1 slow growth suppressor 1
Spo11 sporulation 11
V(D)J variable-diversity-joining recombination
XRCC4 X-ray cross complementation 4
Yen1 yeast endonuclease 1 
©2009 EUROPEAN MOLECULAR BIOLOGY ORGANIZATION EMBO reports VOL 10 | NO 8 | 2009 839
reviewsmeeting repor t
Ku70-deficient cells, and found that the translocation frequency 
could be suppressed to wild-type levels after the reintroduction of 
XRCC4 and Ku70, respectively, into the mutant cells. The sequence 
characteristics of the translocation junction—which include 
microhomology—were similar for the wild-type and mutant cell 
lines, pointing to the involvement of alternative pathways of NHEJ 
in translocation. Jasin also reported on a new technique that uses 
engineered zinc-finger nucleases to induce and quantify trans-
locations in human cells without the need for cell cloning. By using 
this system, Jasin could determine that the aberrant repair of the 
DSBs leads to translocations—as occurs in mouse cells—approxi-
mately one-half of which show microhomology at the breakpoint 
junctions (Brunet et al, 2009). Therefore, this system can be used to 
analyse the role of DNA-repair proteins in human cancers.
DNA repair in lymphocytes
A characteristic of B lymphocytes is their ability to recognize a vast 
array of pathogens. This diversity is achieved, in part, by V(D)J recom-
bination and CSR (Fig 2). Both processes proceed through DSB inter-
mediates and are among the rare instances in which DNA lesions are 
deliberately introduced at defined genomic regions. The regulation 
of the enzymes that generate these lesions and of the proteins that 
repair the resultant DSBs were discussed in depth at this meeting.
Artemis is an endonuclease that cleaves hairpin intermediates 
at coding ends during V(D)J recombination (Sekiguchi & Ferguson, 
2006). Inactive alleles of Artemis lead to severe combined immuno-
deficiency, whereas hypomorphic alleles of Artemis can lead to 
immunodeficiencies of varying severity (Revy et al, 2005). J. Sekiguchi 
(Ann Arbor, MI, USA) generated knock-in mice that phenocopy a 
premature-truncation mutation in the human Artemis protein. The 
mice had a severe reduction in B and T lymphocytes, and a pro-
nounced accumulation of hairpin-coding ends. The mutant cells also 
exhibited DSB-repair defects, indicating that the carboxy terminus 
of Artemis is essential for V(D)J recombination and the maintenance 
of genomic stability (Huang et al, 2009).
CSR occurs between repetitive switch regions, which precede each 
immunoglobulin constant-region gene (Chaudhuri et al, 2007). The 
B cell-specific AID protein deaminates cytidines to uridines within 
trans cribed switch regions, initiating a series of reactions that leads to 
the generation of the DSBs required for CSR (Muramatsu et al, 2007). 
Mutations in AID that block its nuclear export severely impair CSR, 
but do not affect cytidine deamination. To determine whether nucleo-
cytoplasmic shuttling is required for CSR, M. Neuberger (Cambridge, 
UK) mutated the AID nuclear-export signal and/or replaced it with 
one from a heterologous protein (Geisberger et al, 2009). Many of 
the mutant proteins underwent nuclear export, but were severely 
impaired for CSR, which showed that export is necessary but not suf-
ficient for CSR. However, some mutants that allowed nuclear export 
and CSR showed increased protein stability, which indicated that 
the AID nuclear-export signal might mediate interactions with other 
proteins—for example, exportin and/or Crm-1—to generate the high 
density of lesions at switch regions required for CSR.
Chromosomal translocations between the immunoglobulin loci 
and oncogenes are characteristics of B-cell lymphomas. To deter-
mine why some genes are targeted for translocations, M. Lieber (Los 
Angeles, CA, USA) assembled a database of breakpoints from the most 
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Fig 1 | Responses to DNA double-strand breaks in S phase. DSBs that arise during the S phase are rapidly processed by a helicase (SGS1) and exonucleases/
endonucleases (DNA2, ExoI and MRN–SAE2/CtIP) to generate a 3' overhang. HR, which does not induce errors, or BIR, which is error prone, are used in 
higher eukaryotes to repair the lesion depending on the context in which the DSBs arise. BIR, break-induced replication; DNA2, DNA nuclease 2; DSB, 
double-strand break; ExoI, exonuclease I; HR, homologous recombination; MRN, Mre11–Rad50–Nbs1 complex; SAE2/CtIP, sporulation in the absence of 
Spo11/CTBP-interacting protein nuclease; SGS1, slow growth suppressor 1.
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common chromosomal rearrangements (bcl1, bcl2 and E2A) in human 
leuk aemias and lymphomas. His analyses revealed that CpG nucleo-
tides, which constitute only 1% of the human genome, account for 
40–70% of the translocations in early-stage, but not late-stage, B-cell 
lymphomas (Tsai et al, 2008). These translocations probably arise 
owing to AID activity on methylated cytidines (Morgan et al, 2004), 
followed by RAG1/RAG2 activity at the mispaired bases.
The c-Myc oncogene is also a common translocation partner of the 
IgH in patients with Burkitt lymphomas and mice with plasma cytomas 
(Ramiro et al, 2007). To determine whether AID generates DSBs at 
c-Myc, D. Robbiani (New York, NY, USA) used I-SceI to introduce 
DSBs upstream of the IgH-switch region and/or the c-Myc locus. In the 
absence of I-SceI, all c-Myc/IgH translocations were AID dependent. 
By comparison, c-Myc/IgH translocations were observed in activated 
AID-deficient B cells only when I-SceI-induced DSBs were generated 
at both loci. Interestingly, Robbiani showed that the breaks at c-Myc 
are limiting under physio logical conditions (Robbiani et al, 2008). In 
this context, F. Alt (Boston, MA, USA) found that c-Myc expression 
in the translocated IgH/c-Myc allele requires a transcriptional 
enhancer at the 3' end of the IgH locus.
The role of NHEJ in CSR remains ill defined. Both Alt and 
J-P de Villartay (Paris, France) showed that conditional inactiva-
tion of Xrcc4 or DNA ligase IV in mice allows significant levels of 
CSR. K. Yu (East Lansing, MI, USA) arrived at a similar conclusion 
by studying a B-cell line in which DNA ligase IV was inactivated. 
In each study, most switch junctions showed DNA-sequence 
microhomology. Therefore, an alternative end-joining pathway is 
also active in CSR. Indeed, Alt found that Xrcc4-deficient splenic 
B cells accumulate AID-dependent DSBs at the IgH locus on 
chromo some 12 and RAG-dependent DSBs at the Ig light-chain 
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Fig 2 | DNA recombination in B cells. The V, D and J segments are assembled during V(D)J recombination (only the heavy chain locus is shown). The reaction 
is initiated by the RAG1/RAG2 endonuclease. Components of the NHEJ machinery ligate the resultant DSBs. The end product of V(D)J recombination is a 
B cell expressing IgM at its surface. Class-switch recombination occurs between repetitive switch (S) regions (ovals) that precede each constant-region gene. 
Each S region is an independent transcription unit, which is shown by the thick arrows. AID deamination at S regions followed by the activities of base-excision 
repair and/or mismatch repair lead to the formation of DSBs that subsequently are ligated by end joining. The factors that ligate DSBs at the S regions require 
elucidation. RAG1/RAG2 endonuclease and AID deaminase have been implicated in the ontogeny of B-cell lymphomas when their activities are aberrantly 
targeted to non-Ig genes such as c-Myc and other oncogenes. AID, activation-induced cytidine deaminase; c-Myc, avian myelocytomatosis virus oncogene cellular 
homologue; CSR, class-switch recombination; DNAPKcs, DNA-dependent protein kinase catalytic subunit; DSB, double-strand break; Ig, immunoglobulin; 
Ku70, 70 kDa Ku antigen; Ku80, 80 kDa Ku antigen; NHEJ, non-homologous end joining; RAG1/RAG2, recombination-activating genes 1 and 2; V(D)J, variable-
diversity-joining recombination; XRCC4, X-ray cross complementation 4.
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gene on chromosome 16, which could lead to chromosome 12/16 
translocations by alternative end joining. Therefore, although 
it is not strictly required for CSR, classical NHEJ is important for 
maintaining genome stability during CSR.
Together, these talks reiterated that although targeted DNA alter-
ations are essential for immune-system development, mistargeted 
RAG and/or AID activity could lead to the chromosomal trans-
locations that are characteristic of B-cell lymphomas. Similarly, 
DNA-repair proteins that process the DSBs during lymphocyte 
differentiation have to be finely choreographed, as aberrant repair 
might have catastrophic consequences.
Meiotic control of recombination
During meiosis, recombination is initiated at DSBs that are cre-
ated by the conserved Spo11 protein (Keeney & Neale, 2006). 
Repair of these DSBs by HR leads to either a reciprocal exchange 
of DNA between homologues (a crossover) or a non-reciprocal 
transfer of genetic information from one homologue to another (a 
non-crossover). Crossovers are important as they provide a physical 
link between homologues that ensures correct chromosome seg-
regation. The regulation of meiotic recombination ensures that each 
pair of homologues receives at least one crossover event.
Several talks focused on genome-wide approaches to analy se 
the initiation and/or resolution of meiotic-recombination events. 
Previous work in several organisms showed that meiotic DSBs 
are not distributed randomly throughout the genome, but tend 
to cluster in ‘hotspots’. What causes this non-random distri-
bution remains poorly understood. S. Keeney (New York, NY, 
USA) described a high-resolution method to analyse global DSB 
distributions in S. cerevisiae using Spo11-associated oligonucleo-
tide sequences. These experiments refine previous genome-wide 
analy ses of meiotic DSBs, paving the way for a more detailed 
analysis of their reg ulation. Although significant overlap exists 
between the crossover and DSB maps, there are distinct differ-
ences, indicating that crossover placement is subject to additional 
levels of regulation. Phenomena that can potentially account 
for these differences include crossover interference or crossover 
homeostasis, as discussed by J. Fung (San Francisco, CA, USA), 
and inter ference between non-crossover and crossover events 
as presented by E. Mancera (Heidelberg, Germany). Interference 
imposes a more regular spacing of crossovers, whereas crossover 
homeostasis limits the number of crossovers to a tight fluctuation 
about the average.
Two talks highlighting recent work in mice suggested that trans-
acting factors can influence crossover distribution. B. de Massy 
(Montpellier, France) and P. Petkov (Bar Harbor, ME, USA) reported 
the identification of overlapping regions of chromosome 17 that 
influence the activity of recombination hotspots elsewhere in the 
genome. These loci, Dsbc1 (Grey et al, 2009) and Rcr1 (Parvanov 
et al, 2009), neither act through a general activation or suppression of 
all hotspots, nor alter the overall number of crossovers; instead, they 
seem to affect the activity of specific hotpots differentially. In both 
cases, the loci were shown to affect the initiation of recombination 
before the crossover/non-crossover decision is made.
Copy-number variants in the human genome
Several presentations also focused on how CNVs have influenced 
the human genome. CNV is a broad term used to describe DNA 
rearrange ments that arise from chromosomal duplications, deletions, 
inversions, translocations and mobile genetic-element insertions. 
J. Lupski (Houston, TX, USA) introduced the concept of genomic dis-
orders and discussed how non-allelic recombination events between 
highly similar, but non-identical, low-copy number repeated DNA 
sequences can result in distinct genomic disorders (Lupski, 2009). He 
then proposed a fork-stalling and template-switching mechanism that 
might be important in generating non-recurrent DNA rearrangements 
in human cells (Lee et al, 2007). Interestingly, the junction sequences 
at many genomic rearrangements were composed of a patchwork 
of sequences derived from various intrachromosomal locations—
a phenom enon that was also touched on in Stratton’s talk. It will be 
interesting to see whether some mutations observed in tumours occur 
by a similar mechanism.
M. Hurles (Cambridge, UK) discussed how his colleagues at the 
Sanger Institute (Cambridge, UK), in Boston (MA, USA) and in Toronto 
(Canada) have amassed a near complete map of common CNVs in the 
human genome. The map comprises approximately 11,000 CNVs that 
are more than 1 kb in length and some generalizations are becoming 
evident. First, it seems that CNVs are relatively common and might 
arise by distinct molecular mechanisms—for example, non-allelic 
homologous recombination, fork stalling and template switching, 
and/or retrotransposition—that often leave signatures in the resulting 
alleles. Second, genome architecture might predispose certain regions 
of human DNA to these types of rearrangement.
The idea that sequence context might predispose certain chromo-
somal regions to rearrangements was addressed by B. Emanuel 
(Philadelphia, PA, USA), who reported that nearly perfect palin-
dromic AT-rich DNA-repeat sequences on human chromosome 
22q11 might form stem–loop and/or cruciform-like structures, pre-
disposing them to disease-producing meiotic DNA translocations 
with other genomic regions such as 11q23 and 8q24.1. These trans-
location partners also contain AT-rich palindromes, providing support 
for the role of palindromic sequences in genomic instability. S. Lewis 
(Boston, MA, USA) discussed in vitro findings in yeast and mamma-
lian cells, and showed that extended palindromic sequences could 
be extruded from DNA to form cruciform structures. The process-
ing of these cruciforms in the cell could lead to DSBs, resulting in 
both subtle and large-scale genomic DNA rearrangements. Lewis 
also presented a model called palindrome revision, and suggested 
that subtle rearrangements at extruded palindromic sequences might 
act to ‘disable’ them before they can lead to more serious genome 
disruptions. It will be interesting to see whether small central dele-
tions at other palin dromic sequences in human DNA render them 
‘immune’ to subsequent gross chromosomal rearrangements.
Concluding remarks
The 2009 Keystone Symposium on Genome Instability and DNA 
Repair provided an opportunity to present data, exchange ideas and 
spend time with like-minded colleagues. The meeting highlighted the 
many pathways used by cells to deal with genotoxic stress effectively, 
and how they are used to repair deliberate lesions introduced during 
the processes of immune-gene diversification and meiosis. Indeed, 
the knowledge obtained from in vitro experiments and in vivo studies 
in model organisms—only a few of which could be mentioned here—
should be instrumental in determining how the complex genomic 
rearrangements observed in cancer and human genomic disorders 
arise. We predict that this will be a fertile area of research for years to 
come, and thank M. Jasin, S. Elledge and M. Neuberger for bringing us 
together to discuss cutting-edge issues on this topic.
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